IRIS
PISANI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 83.341
AS - Asia 8.505
EU - Europa 6.336
SA - Sud America 1.253
Continente sconosciuto - Info sul continente non disponibili 842
AF - Africa 94
OC - Oceania 16
Totale 100.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 82.900
SG - Singapore 4.023
CN - Cina 1.564
UA - Ucraina 1.054
BR - Brasile 998
IT - Italia 995
HK - Hong Kong 953
RU - Federazione Russa 921
DE - Germania 841
IE - Irlanda 818
VN - Vietnam 538
KR - Corea 463
FR - Francia 390
GB - Regno Unito 347
SE - Svezia 339
BD - Bangladesh 283
FI - Finlandia 249
JP - Giappone 209
CA - Canada 185
IN - India 104
NL - Olanda 89
AR - Argentina 84
PL - Polonia 66
ID - Indonesia 57
MX - Messico 55
EC - Ecuador 43
ES - Italia 42
TR - Turchia 41
CR - Costa Rica 40
IQ - Iraq 37
CO - Colombia 35
AT - Austria 31
CL - Cile 30
BE - Belgio 28
EU - Europa 26
JM - Giamaica 26
ZA - Sudafrica 24
CZ - Repubblica Ceca 20
NI - Nicaragua 20
TH - Thailandia 20
PK - Pakistan 19
VE - Venezuela 19
KG - Kirghizistan 18
PR - Porto Rico 17
SV - El Salvador 17
PY - Paraguay 16
CH - Svizzera 15
GT - Guatemala 15
KE - Kenya 15
PH - Filippine 15
AE - Emirati Arabi Uniti 14
AU - Australia 14
JO - Giordania 14
MY - Malesia 14
UZ - Uzbekistan 14
HN - Honduras 13
IL - Israele 12
IR - Iran 12
SA - Arabia Saudita 12
TT - Trinidad e Tobago 12
LT - Lituania 11
NP - Nepal 11
RO - Romania 11
PT - Portogallo 10
TN - Tunisia 10
AL - Albania 9
DZ - Algeria 9
MA - Marocco 9
PE - Perù 9
GP - Guadalupe 8
TW - Taiwan 8
UY - Uruguay 8
AZ - Azerbaigian 7
EG - Egitto 7
GE - Georgia 7
KZ - Kazakistan 7
OM - Oman 7
BO - Bolivia 6
GR - Grecia 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
DK - Danimarca 5
DM - Dominica 5
EE - Estonia 5
RS - Serbia 5
BB - Barbados 4
BZ - Belize 4
DO - Repubblica Dominicana 4
HT - Haiti 4
KW - Kuwait 4
LB - Libano 4
MT - Malta 4
PS - Palestinian Territory 4
BY - Bielorussia 3
GY - Guiana 3
MD - Moldavia 3
NO - Norvegia 3
SC - Seychelles 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
Totale 99.528
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.875
Wilmington 20.335
Houston 18.829
Fairfield 2.674
Ashburn 2.121
Singapore 1.987
Ann Arbor 1.796
San Jose 1.144
Seattle 1.090
Chandler 1.006
Jacksonville 948
Hong Kong 939
Cambridge 914
Dublin 759
Medford 549
Beijing 531
Santa Clara 398
Dearborn 365
Council Bluffs 361
New York 328
The Dalles 288
Rome 267
Lawrence 261
Los Angeles 240
Menlo Park 196
Buffalo 168
Tokyo 168
Moscow 163
Lauterbourg 160
Ho Chi Minh City 157
Zhengzhou 146
Hanoi 136
Dallas 115
São Paulo 109
Milan 106
San Diego 100
North Bergen 84
Mülheim 82
Munich 68
London 64
Chicago 57
Atlanta 51
Denver 49
Norwalk 49
Nanjing 47
Mountain View 45
Shanghai 45
University Park 45
Rio de Janeiro 42
Hefei 41
Montreal 41
Orem 41
Helsinki 40
Redondo Beach 40
Falls Church 38
Toronto 38
Brooklyn 37
Guangzhou 35
Verona 35
Warsaw 35
Carrboro 34
Detroit 34
Redwood City 34
Kunming 33
Phoenix 33
Columbus 31
Nuremberg 29
Philadelphia 29
Mcallen 28
San Mateo 28
Jakarta 27
Saint Petersburg 26
San Francisco 26
Frankfurt am Main 25
San José 25
Brussels 24
Belo Horizonte 23
Palo Alto 23
Amsterdam 22
Da Nang 22
Manchester 22
Naples 22
Redmond 22
Stockholm 22
Miami 21
Boston 20
Brasília 20
Genoa 20
Kraków 20
Monmouth Junction 20
Charlotte 19
Hangzhou 19
Mexico City 19
Mumbai 19
Quito 19
Chennai 18
Boardman 17
Brno 17
Kingston 17
Managua 17
Totale 84.824
Salva come PNG Salva come JPEG
Nome #
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process 649
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 531
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 518
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 516
Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: Implications for its antiepileptic activity 506
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 505
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 502
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 501
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 500
Synaptic transmission in the striatum: from plasticity to neurodegeneration 496
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 494
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 490
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 488
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 488
Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice 488
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 485
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 485
Muscarinic IPSPs in rat striatal cholinergic interneurones 484
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis 484
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 482
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 481
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 479
Homeostatic changes of the endocannabinoid system in Parkinson's disease. 479
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 478
Distinct roles of group I mGlu receptors in striatal function 478
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 477
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 475
Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia 475
Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: Role of M1 muscarinic receptors 473
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 472
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 471
Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons 471
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 469
Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): a case report 467
Re-emergence of striatal cholinergic interneurons in movement disorders 465
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 463
Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro 463
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 462
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 462
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 462
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 461
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons 461
The Italian Dystonia Registry: rationale, design and preliminary findings 461
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 460
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 459
An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study 459
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. 457
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 456
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 456
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 454
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 453
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 451
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 450
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 449
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: a case report 448
Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients 448
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia 448
Facial diplegia resembling bilateral Ramsay Hunt Syndrome 448
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 447
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine 447
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 446
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 446
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1 445
Synaptic plasticity in the ischaemic brain 445
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine 445
Centrality of striatal cholinergic transmission in Basal Ganglia function 445
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity 444
Hyperkinetic disorders and loss of synaptic downscaling 444
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 444
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 442
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 442
Outward potassium currents activated by depolarization in rat globus pallidus 441
Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine 440
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 440
Persistent chorea in DYT6, due to anticholinergic therapy 440
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 439
Role of Ca2+ in striatal LTD and LTP 439
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 438
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 438
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 438
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 437
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 437
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 437
Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease 436
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity 436
CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report 436
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 435
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 435
Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses 434
Tissue plasminogen activator is required for corticostriatal long-term potentiation 434
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 434
Basic research in substantia nigra and ventral tegmental area: clinical implications 434
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 433
Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons 432
Engineering animal models of dystonia 432
Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA 432
Double hit mouse model of Parkinson's disease 432
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease 431
Morphological and functional study of dwarf neurons in the rat striatum 431
Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors 430
Totale 46.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 229.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 229.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.178 0 0 0 148 39 280 252 114 152 294 148 751
2022/20232.836 365 221 79 316 202 765 264 151 228 6 167 72
2023/2024983 108 34 66 20 89 234 39 110 66 21 4 192
2024/20256.039 147 1.447 643 321 155 430 370 226 485 484 769 562
2025/20268.695 694 446 1.095 685 728 264 1.027 1.183 959 803 459 352
2026/20273.882 527 537 1.744 1.074 0 0 0 0 0 0 0 0
Totale 100.387